相关实验视频

Updated: Jun 29, 2025

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis

Published on: April 5, 2017

一个移动健康应用程序的可用性测试,以支持活跃结核病患者:一项混合方法研究

Alexander John Stabile¹, Sarah Iribarren¹, Jennifer Sonney²

¹Biobehavioral Nursing and Health Informatics, University of Washington, Seattle, Washington, USA.

Informatics for health & social care

|March 26, 2024

概括

数字坚持技术可以改善结核病 (TB) 治疗. 一个移动应用程序,结核病治疗支持工具 (TB-TST),显示出高可用性,并进行代改进,以增强以患者为中心的护理.

科学领域:

数字健康数字健康
移动健康移动健康移动健康移动健康
公共卫生公共卫生

背景情况:

对结核病 (TB) 治疗的不良坚持有助于疾病传播,不良结果和耐药性.
数字坚持技术提供了以患者为中心的方法,以改善结核病治疗结果.
评估和完善移动健康 (mHealth) 应用程序对于有效实施至关重要.

研究的目的:

评估结核病治疗支持工具 (TB-TST) 移动应用程序的可用性.
通过代改进探索改善TB-TST应用程序可用性的方法.
评估混合方法设计在完善mHealth工具对结核病治疗坚持的有效性.

主要方法:

采用了一种代的融合混合方法设计.
在三个测试周期中进行了两个定量调查 (MAUQ,Health-ITUES) 和定性思考大声采访.
数据被主题分析,并用于代的应用程序改进.

主要成果:

参与者认为TB-TST应用程序具有很高的可用性.
基于参与者反的代改进在定性访谈中得到了积极的接受.
尽管进行了改进,但在测试周期之间没有观察到量化可用性得分的统计学上显著改善.

结论:

一个代的融合混合方法设计是有效的完善mHealth应用程序,如TB-TST.
参与者的反对于识别和解决应用程序设计改进的关键领域至关重要.
虽然可用性很高,但为了优化结核病治疗支持工具,需要不断改进.

关键词:

可用性测试可用性测试数字化坚持技术的技术.药物治疗的坚持药物治疗的坚持移动健康的移动健康结核病是一种肺结核病.

更多相关视频

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis

Published on: August 11, 2008

Author Spotlight: Developing a Point-of-Care Hemoglobin Estimation Method for Anemia Management

Author Spotlight: Developing a Point-of-Care Hemoglobin Estimation Method for Anemia Management

Published on: January 19, 2024

相关概念视频

Pulmonary Tuberculosis V

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...

Pulmonary Tuberculosis IV

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...

Pulmonary Tuberculosis I

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...